Sawyer & Company Inc Purchases New Holdings in Stryker Corporation $SYK

Sawyer & Company Inc acquired a new position in Stryker Corporation (NYSE:SYK) in the third quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 4,878 shares of the medical technology company’s stock, valued at approximately $1,343,000.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Sowell Financial Services LLC raised its stake in Stryker by 31.5% during the 3rd quarter. Sowell Financial Services LLC now owns 1,730 shares of the medical technology company’s stock valued at $476,000 after purchasing an additional 414 shares during the period. Bell Bank grew its holdings in shares of Stryker by 3.4% during the third quarter. Bell Bank now owns 1,052 shares of the medical technology company’s stock valued at $290,000 after buying an additional 35 shares in the last quarter. Eagle Harbor Asset Management Inc. ADV raised its position in Stryker by 94.4% during the third quarter. Eagle Harbor Asset Management Inc. ADV now owns 2,535 shares of the medical technology company’s stock valued at $698,000 after buying an additional 1,231 shares during the period. Cushing Capital Partners LLC raised its position in Stryker by 13.6% during the third quarter. Cushing Capital Partners LLC now owns 1,517 shares of the medical technology company’s stock valued at $418,000 after buying an additional 182 shares during the period. Finally, Pinnacle Associates Ltd. purchased a new stake in Stryker in the 3rd quarter worth about $3,501,000. Institutional investors and hedge funds own 77.09% of the company’s stock.

Stryker Stock Down 2.3%

SYK traded down $7.07 during midday trading on Wednesday, hitting $297.33. 1,193,869 shares of the company’s stock traded hands, compared to its average volume of 2,450,214. The company has a market cap of $114.05 billion, a PE ratio of 30.77, a price-to-earnings-growth ratio of 1.92 and a beta of 0.78. The stock’s fifty day simple moving average is $297.53 and its 200-day simple moving average is $312.37. The company has a debt-to-equity ratio of 0.59, a current ratio of 2.16 and a quick ratio of 1.33. Stryker Corporation has a one year low of $267.00 and a one year high of $392.55.

Stryker (NYSE:SYK) last posted its earnings results on Thursday, July 30th. The medical technology company reported $3.69 EPS for the quarter, topping the consensus estimate of $3.49 by $0.20. Stryker had a net margin of 14.43% and a return on equity of 23.63%. The company had revenue of $6.59 billion during the quarter, compared to the consensus estimate of $6.58 billion. During the same period in the previous year, the firm posted $3.13 earnings per share. The company’s revenue for the quarter was up 9.4% compared to the same quarter last year. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. As a group, equities analysts anticipate that Stryker Corporation will post 14.93 earnings per share for the current fiscal year.

Stryker Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be issued a $0.88 dividend. The ex-dividend date is Wednesday, September 30th. This represents a $3.52 dividend on an annualized basis and a yield of 1.2%. Stryker’s dividend payout ratio is currently 36.48%.

Insider Buying and Selling

In other Stryker news, insider Dylan Crotty sold 441 shares of the stock in a transaction on Friday, August 21st. The shares were sold at an average price of $328.61, for a total transaction of $144,917.01. Following the transaction, the insider directly owned 6,102 shares of the company’s stock, valued at $2,005,178.22. This represents a 6.74% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Debra King sold 826 shares of the firm’s stock in a transaction dated Tuesday, August 18th. The shares were sold at an average price of $336.30, for a total value of $277,783.80. Following the transaction, the insider owned 6,210 shares in the company, valued at approximately $2,088,423. This trade represents a 11.74% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders sold 351,267 shares of company stock worth $118,197,701. Corporate insiders own 4.60% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on SYK shares. Evercore set a $350.00 price objective on Stryker in a research report on Monday, July 6th. Raymond James Financial set a $370.00 price target on shares of Stryker in a research report on Friday, July 31st. Wells Fargo & Company decreased their price target on shares of Stryker from $418.00 to $348.00 and set an “overweight” rating for the company in a report on Wednesday, September 9th. Stifel Nicolaus lowered their price objective on shares of Stryker from $360.00 to $330.00 and set a “buy” rating on the stock in a research report on Wednesday, September 30th. Finally, Wall Street Zen lowered shares of Stryker from a “buy” rating to a “hold” rating in a research note on Saturday, October 3rd. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and six have issued a Hold rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $369.00.

Stryker Company Profile

Stryker Corporation (NYSE: SYK) is a global medical technology company that develops and manufactures products used by healthcare providers in hospitals, surgical centers and other clinical settings. Its offerings are designed to support orthopaedic procedures, surgery, emergency care, neurovascular treatment and patient handling.

The company’s product portfolio includes orthopaedic implants and instruments, products for trauma and spine procedures, surgical equipment, endoscopy systems, patient beds and stretchers, emergency medical equipment, and neurovascular devices used in the treatment of conditions such as stroke.